TEVA PHARMACEUTICAL INDUSTRIES LIMITED
5 Basel St – Petach Tivka – 49131
VAT: IL557410149
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, TEVA PHARMACEUTICAL INDUSTRIES LIMITED has received € 260,300.0 for its participation in a total of 11 project(s) with a total cost of € 328,276,543.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-09-01 | 831458 | Trials@Home | 2024-08-31 | participant | € 0.0 | € 39,148,297 | 1 | 33 | CORDIS ↪ | |
| 2018-03-01 | 765497 | THERACAT | entrepreneurship · pharmaceutical drugs · oncology · catalysis | 2022-08-31 | participant | € 260,300.52 | € 3,380,767 | 2 | 9 | CORDIS ↪ |
| 2019-04-01 | 820820 | MOBILISE-D | drug discovery · multiple sclerosis · sensors · health care services · cardiology | 2024-03-31 | participant | € 0.0 | € 49,911,564 | 2 | 38 | CORDIS ↪ |
| 2021-07-01 | 101007939 | RealHOPE | proteins · pharmacology and pharmacy | 2025-06-30 | participant | € 0.0 | € 7,132,608 | 1 | 27 | CORDIS ↪ |
| 2019-02-01 | 821522 | PD-MitoQUANT | biochemistry · parkinson | 2022-07-31 | participant | € 0.0 | € 6,894,315 | 1 | 15 | CORDIS ↪ |
| 2019-04-01 | 821520 | ConcePTION | governance · pharmaceutical drugs · obstetrics · ecosystems | 2024-03-31 | participant | € 0.0 | € 28,657,491 | 3 | 65 | CORDIS ↪ |
| 2017-10-01 | 777364 | EQIPD | neurobiology · data science · alzheimer · governance · machine learning | 2021-09-30 | participant | € 0.0 | € 9,360,691 | 1 | 31 | CORDIS ↪ |
| 2019-11-01 | 853966 | EU-PEARL | governance · tuberculosis | 2023-04-30 | participant | € 0.0 | € 25,938,047 | 1 | 41 | CORDIS ↪ |
| 2021-11-01 | 101034344 | EPND | neurobiology · data science · alzheimer · parkinson | 2026-10-31 | participant | € 0.0 | € 19,005,502 | 1 | 29 | CORDIS ↪ |
| 2018-04-01 | 777500 | IMI-PainCare | drug discovery · surgery · pharmaceutical drugs · pathophysiology · pharmacokinetics | 2023-03-31 | participant | € 0.0 | € 23,405,673 | 1 | 41 | CORDIS ↪ |
| 2018-06-01 | 777394 | AIMS-2-TRIALS | epilepsy · personalized medicine | 2025-05-31 | participant | € 0.0 | € 115,441,584 | 1 | 57 | CORDIS ↪ |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED did not participate in complicit projects under Horizon Europe (2021-2027).
TEVA PHARMACEUTICAL INDUSTRIES LIMITED did not participate in complicit projects under FP7 (2007-2013).